Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-2,000
Closed -$328K 210
2017
Q1
$328K Buy
+2,000
New +$332K 0.01% 189
2016
Q4
Sell
-3,506
Closed -$585K 211
2016
Q3
$585K Buy
+3,506
New +$593K 0.01% 157
2016
Q1
Sell
-4,400
Closed -$714K 234
2015
Q4
$714K Buy
4,400
+2,300
+110% +$362K 0.01% 173
2015
Q3
$290K Buy
+2,100
New +$331K ﹤0.01% 218

Other funds holding AMGN

Soros Fund Management's AMGN Position: Q2 2017 in Review

Soros Fund Management sold out of Amgen (AMGN) in Q2 2017, closing a stake of 2,000 shares — an estimated $328K sold.

Soros Fund Management first reported a position in AMGN in Q3 2015 and held it in 4 quarters. The position peaked at $714K in Q4 2015. 1,595 funds tracked by Wall St. Rank hold AMGN as of Q2 2017.

  • Soros Fund Management reported no remaining Amgen position as of Q2 2017 after selling out during the quarter.
  • Soros Fund Management sold 2,000 Amgen shares in Q2 2017, an estimated $328K.
  • Soros Fund Management first reported a position in Amgen in Q3 2015 and held it in 4 quarters.
  • Soros Fund Management's Amgen position peaked at $714K in Q4 2015.
  • 1,595 funds tracked by Wall St. Rank held Amgen as of Q2 2017.

Based on Soros Fund Management's 13F filing for Q2 2017, filed 14 Aug 2017.